English(EN) The ‘Natural’ Supplement Sending People To The ICU

FDA调查与ICU入院相关的卡痛补充剂

作者 PulseAugur 编辑部 · [1 个来源] · 2026-10-01 22:41

美国食品药品监督管理局（FDA）正在调查一种上市已超过十年的卡痛补充剂，因其可能导致严重的健康问题。卡痛含有与阿片类受体相互作用的化合物，引发了对其安全性和滥用潜力的担忧。该机构正在收集数据以评估其消费相关的风险。 AI

影响此次调查凸显了监管天然补充剂的挑战以及与阿片类受体相互作用的产品相关的潜在健康风险。

排序理由 FDA正在根据报告的不良事件调查一种补充剂，这属于监管和安全研究范畴。（lever_c_demoted from research: ic=1 ai=0.4）

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 0 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Tool; FDA正在根据报告的不良事件调查一种补充剂，这属于监管和安全研究范畴。（lever_c_demoted from research: ic=1 ai=0.4）
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: safety, policy; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: Standard; On-topic for AI-industry coverage; kept in the public index.
Story freshness: 7 days old; Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

完整方法见我们的编辑标准。

Forbes — Innovation TIER_1 English(EN) · Robert Glatter, MD, Contributor · 2026-10-01 22:41

导致人们住进ICU的“天然”补充剂

Marketed for over a decade as a natural wellness product, kratom contains mitragynine and its derivative 7-hydroxymitragynine, which both interact with opioid receptors.